Mylan Pharmaceuticals announced July 14 it is buying Abbott Laboratories' non-U.S. developed markets specialty and branded generics business in an all-stock transaction worth $5.3 billion.
Read more
Rep. David B. McKinley, P.E. (R-W.Va.) released the following breakdown of his Congressional work for the first six months of this year. Here's a look at the work in both the First District and Washington, D.C., by the numbers:
Read more
Cliffs Natural Resources has issued a notice of preliminary plans to idle the Pinnacle Mine in Wyoming County at the end of August impacting 450 miners.
Read more
McKinley's Field Representative Lianna Phillips will be at the following locations for those who have questions about issues or any other concerns. All constituents are welcome.
Read more
The jury's still out on whether Monday's Supreme Court ruling will have any effect on the Environmental Protection Agency's proposed rule to limit carbon emissions from power plants.
Read more
McKinley asked Assistant Administrator Janet McCabe why the U.S. should put its economy at risk while China and other nations increase emissions.
Read more
U.S. Rep. David McKinley, R-W.Va., deserves the praise he has received for dealing with an important issue. He and other thoughtful, reasonable members of Congress must be frustrated his initiative has stalled in the U.S. Senate.
Read more
U.S. Reps. Nick Rahall, D-W.Va., and David McKinley, R-W.Va., introduced the Protection and Accountability Regulatory Act of 2014 on Tuesday, which would block the proposed rule for both existing and future power plants, and would prevent the issuance of similar rules for five years.
Read more
